| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/05/2003 | EP1286663A2 Encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 03/05/2003 | EP1286662A1 Tablets and methods for modified release of hydrophilic and other active agents |
| 03/05/2003 | EP1286661A2 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations |
| 03/05/2003 | EP1286659A2 Macromolecular drug complexes and compositions containing the same |
| 03/05/2003 | EP1286658A2 Y-ifn liquid-droplet aerosol and method |
| 03/05/2003 | EP1286655A1 Topical composition containing at least one aryl oxime, and method for the preparation thereof |
| 03/05/2003 | EP1286652A2 Skin protectant spray compositions |
| 03/05/2003 | EP1173138B1 Cosmetic or pharmaceutical utilisation of nanoscalic metal soaps |
| 03/05/2003 | EP1131059B1 Dry powder for inhalation |
| 03/05/2003 | EP1115406A4 Sustained release, and comfortable ophthalmic composition and method for ocular therapy |
| 03/05/2003 | EP1089714B1 Processes to generate particles of water-insoluble compounds of up to 2000 nm in size |
| 03/05/2003 | EP0971692B1 Specific magnetosome, method for the production and use thereof |
| 03/05/2003 | EP0952829B1 Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same |
| 03/05/2003 | EP0932417B1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 03/05/2003 | EP0930070B1 Stable aspirin ointment preparations |
| 03/05/2003 | EP0895474A4 Liquid eye drop composition |
| 03/05/2003 | EP0835262B1 Method for the treatment of corticosteroid induced osteopenia |
| 03/05/2003 | EP0774898B1 Methods of making sustained release biocidal compositions |
| 03/05/2003 | EP0724457B1 Radiation sensitization using texaphyrins |
| 03/05/2003 | EP0712293B1 Method of preparing gas-filled lipid microspheres and gas-filled lipid microspheres |
| 03/05/2003 | EP0554352B1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 03/05/2003 | CN1400910A Factor VII or VIIa like molecules |
| 03/05/2003 | CN1400902A Oral formulation comprising an inhibitor compound of the ileal bile transport and on HMG CO-A reductase inhibitor |
| 03/05/2003 | CN1400897A Transdermal delivery LASOFOXIFENE |
| 03/05/2003 | CN1400896A Ibuprofen containing active agent preparation |
| 03/05/2003 | CN1400894A Plaster containing an active agent |
| 03/05/2003 | CN1400893A Delivery systems using preformed biodegadable polymer compositions and methods |
| 03/05/2003 | CN1400892A Pharmaceutical composition for intramuscular injection containing loxoprofen |
| 03/05/2003 | CN1400870A Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 03/05/2003 | CN1400232A Polyoxyalkylene derivative and its prepn |
| 03/05/2003 | CN1102646C Process for back extraction of medicinal plant oil with supercritical CO2 |
| 03/05/2003 | CN1102410C Mupirocin calcium salt emulsifiable paste composition |
| 03/05/2003 | CN1102408C Stable, aqueous alpha interferon solution formulations |
| 03/05/2003 | CN1102392C Quick soluble breviscapine B tablet its preparation |
| 03/05/2003 | CN1102385C Rapidly disintegrating medicinal form of tramadol or tramadol salt |
| 03/05/2003 | CN1102382C Preparation and methods for the treatment of T cell mediated diseases |
| 03/05/2003 | CN1102379C Dispersible particulate system for desensitizing teeth |
| 03/04/2003 | US6528643 Lipase-catalyzed alcoholysis; cheap starting material; efficiency |
| 03/04/2003 | US6528631 Folates are conjugated to an oligonucleotide including at the 2'-, 3'-, 5'-, nucleobase and internucleotide linkage sites; improved transfer across cellular membranes; regioselective synthesis |
| 03/04/2003 | US6528624 Comprising a human IgG Fc region with amino acid substitution at two or more positions; displays altered effector function; C1q binding affinity; complement dependent cytotoxicity |
| 03/04/2003 | US6528575 Crosslinked polymers obtainable by precipitation polymerization; cosmetics, pharmaceuticals |
| 03/04/2003 | US6528545 Surfactant, perfluorooctyl bromide; superior emulsion stability and controlled particle sizes |
| 03/04/2003 | US6528542 Adjustment concentration |
| 03/04/2003 | US6528540 Administering by injection |
| 03/04/2003 | US6528511 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 03/04/2003 | US6528486 Peptide agonists of GLP-1 activity |
| 03/04/2003 | US6528485 Human growth hormone releasing factor-PEG conjugates; PEG unit is covalently bound to the amino group of Lys21 of SEQ ID NO:1; the hGRF-PEG conjugate does not contain a triazine group |
| 03/04/2003 | US6528483 Method of producing concentrated non-buffered solutions of fibronectin |
| 03/04/2003 | US6528098 Viricides |
| 03/04/2003 | US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation |
| 03/04/2003 | US6528093 Sustained-release preparation |
| 03/04/2003 | US6528089 Solid dosage forms are obtained by mixing at least one polymeric binder, at least one active ingredient, and additives to form a plastic mixture, and shaping, using as polymeric binder a copolymer of an N-vinyllactam |
| 03/04/2003 | US6528087 Kits for forming protein-linked lipidic microparticles |
| 03/04/2003 | US6528086 Methods and apparatus for drug delivery involving phase changing formulations |
| 03/04/2003 | US6528084 Composition and method |
| 03/04/2003 | US6528080 Flowable, biocompatible, branched thermoplastic polymer used to form solid matrices such as implants and controlled-release, drug-formulations in a body |
| 03/04/2003 | US6528076 Acetone, a salicylate-based compound and an emollient. |
| 03/04/2003 | US6528074 Lipid composition containing a liquid crystal structure |
| 03/04/2003 | US6528067 Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
| 03/04/2003 | US6528051 Targeted delivery system comprising at least one component-specific immunostimulating molecule bound to a platform. |
| 03/04/2003 | US6528048 Ophthalmic solutions |
| 03/04/2003 | US6528040 EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic |
| 03/04/2003 | CA2400565A1 Biomodulated multiparticulate formulations |
| 02/28/2003 | CA2420850A1 Solution formulations having long-term stability |
| 02/27/2003 | WO2003016915A1 Tumor specific oligosaccharide sequences and use thereof |
| 02/27/2003 | WO2003016522A2 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | WO2003016469A2 Chemo-enzymatic synthesis of sialylated oligosaccharides |
| 02/27/2003 | WO2003016337A1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope |
| 02/27/2003 | WO2003015831A1 Gas microsphere liposome composites |
| 02/27/2003 | WO2003015828A1 Parenteral formulations of 1-(5-tert-butyl-2-p-tolyl-2h-pryrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea and a cyclodextrin |
| 02/27/2003 | WO2003015827A1 Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
| 02/27/2003 | WO2003015826A1 Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastsis or preventing the recurrence of maligant tumor |
| 02/27/2003 | WO2003015825A2 Conjugate |
| 02/27/2003 | WO2003015824A1 Sustained-release medicinal compositions |
| 02/27/2003 | WO2003015822A1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 02/27/2003 | WO2003015821A1 Topical composition, topical composition precursor, and methods for manufacturing and using |
| 02/27/2003 | WO2003015818A1 Treating, preventing, or detecting angiogenesis with an anti-a2b antibody |
| 02/27/2003 | WO2003015811A1 Process for obtaining a pharmaceutical composition |
| 02/27/2003 | WO2003015809A2 Antimicrobial cationic peptides and formulations thereof |
| 02/27/2003 | WO2003015802A1 Composition for treatment of articular cartilage damage |
| 02/27/2003 | WO2003015796A1 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier |
| 02/27/2003 | WO2003015793A1 Delayed and sustained drug release |
| 02/27/2003 | WO2003015759A2 Treatment of hyperproliferative conditions of body surfaces |
| 02/27/2003 | WO2003015758A1 Sustained release micropellets and process for producing the same |
| 02/27/2003 | WO2003015757A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 02/27/2003 | WO2003015756A1 Preparation of microparticles |
| 02/27/2003 | WO2003015755A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 02/27/2003 | WO2003015751A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 02/27/2003 | WO2003015748A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/27/2003 | WO2003015745A1 Expandable gastric retention device |
| 02/27/2003 | WO2003015744A1 Chitin microparticles and their medical uses |
| 02/27/2003 | WO2003015729A1 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 02/27/2003 | WO2003015714A2 Compositions and therapeutic methods for viral infection |
| 02/27/2003 | WO2003015708A2 Composition and method for treating hiv infection |
| 02/27/2003 | WO2003015699A2 Topical compositions and methods for treating pain |
| 02/27/2003 | WO2003015694A2 Agents for enhancing the immune response |
| 02/27/2003 | WO2003015690A2 Method for treating primary insomnia |
| 02/27/2003 | WO2003015678A1 Composition and transdermal drug delivery device |
| 02/27/2003 | WO2003015677A1 Nitric oxide releasing eptfe coated medical device sandwich |
| 02/27/2003 | WO2003015656A2 Oral care substance delivery strip |